Evolent Health (EVH) Shares Outstanding (2014 - 2026)

Evolent Health has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $113.1 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 3.79% year-over-year to $113.1 million in Q2 2026; TTM through Jun 2026 was $113.1 million, a 3.79% decrease from a year earlier, with the FY2025 full-year figure at $111.6 million, down 4.25% from the prior year.
• Shares Outstanding (Entity) was $113.1 million for Q2 2026 at Evolent Health, up from $112.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $117.5 million in Q2 2025, with the low at $91.6 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $111.2 million, with a median of $113.2 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) climbed 23.54% in 2023, then slipped 4.26% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $111.1 million in 2022, then climbed by 3.94% to $115.4 million in 2023, then rose by 1.01% to $116.6 million in 2024, then decreased by 4.25% to $111.6 million in 2025, then advanced by 1.27% to $113.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $113.1 million (Q2 2026), $112.5 million (Q1 2026), and $111.6 million (Q4 2025), per Business Quant data.